PALISADE BIO, INC.
Company Stats
- Market Cap
- $235.3M
- as of Sep 30, 2026
- Shares Outstanding
- 174.3M
- Free Float
- 82.3%
Income Statement
- Revenue
- $0
- Operating Income
- -$18.1M
- Net Income
- -$16.8M
- EBITDA
- -$18.1M
Balance Sheet
- Cash & Equivalents
- $133.4M
Returns & Capital
- SBC, 3Y Avg
- $1.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | — | — |
| FY2024 | $0 | -$12.2M | — |
| FY2023 | $250,000 | -$11.1M | -4454.8% |
| FY2022 | $0 | -$13.4M | — |
| FY2021 | — | -$14.8M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back